[Differential diagnosis of aminazine jaundice and viral hepatitis developing during aminazine treatment].
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001799:Blood Sedimentation; D002746:Chlorpromazine / Q000009:adverse effects*; D002779:Cholestasis / Q000209:etiology; D002784:Cholesterol / Q000097:blood; D004796:Clinical Enzyme Tests; D003937:Diagnosis, Differential; D004804:Eosinophils; D005260:Female; D005632:Fructose; D005634:Fructose-Bisphosphate Aldolase / Q000097:blood; D006506:Hepatitis A / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000201:enzymology; D006801:Humans; D007565:Jaundice / Q000139:chemically induced*; D007958:Leukocyte Count; D008107:Liver Diseases / Q000150:complications*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged
D005632:Fructose; D002784:Cholesterol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D005634:Fructose-Bisphosphate Aldolase; D002746:Chlorpromazine
K voprosu differentsial'noĭ diagnostiki aminazinovykh zheltukh i virusnogo gepatita, voznikshego na fone priema aminazina.